0001209191-17-041385.txt : 20170622 0001209191-17-041385.hdr.sgml : 20170622 20170622162942 ACCESSION NUMBER: 0001209191-17-041385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170622 DATE AS OF CHANGE: 20170622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stein Steven H CENTRAL INDEX KEY: 0001673776 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 17925401 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-20 0 0000879169 INCYTE CORP INCY 0001673776 Stein Steven H 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP & Chief Medical Officer Common Stock 2017-06-20 4 M 0 3870 95.76 A 18518 D Common Stock 2017-06-20 4 M 0 6013 88.68 A 24531 D Common Stock 2017-06-20 4 S 0 3870 125.00 D 20661 D Common Stock 2017-06-20 4 S 0 6013 125.00 D 14648 D Non-Qualified Stock Option (right to buy) 95.76 2017-06-20 4 M 0 3870 0.00 D 2023-01-06 Common Stock 3870 9392 D Non-Qualified Stock Option (right to buy) 88.68 2017-06-20 4 M 0 6013 0.00 D 2022-03-01 Common Stock 6013 9878 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. This includes an 14,648 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Steven Stein 2017-06-22